Call for cancer warning on heartburn drugs

2 May 2017 - Deborah Wilkes

Archived

The US Esophageal Cancer Action Network (ECAN) is calling for a cancer warning to be added to all OTC medicines for relieving or preventing heartburn associated with reflux disease, acid indigestion and sour stomach.

Click tags below for more information on topics:

FDA

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: